Sinopharm Covid-19 Vaccine
- All
- News
-
UK To Recognise Covaxin, No Quarantine For Fully Vaccinated Travellers
Britain said it would recognise COVID-19 vaccines on the World Health Organization's Emergency Use Listing later this month, adding China's Sinovac, Sinopharm and India's Covaxin to the country's approved list of vaccines for inbound travellers.
-
WHO Experts Recommend 3rd Dose For Over-60s Jabbed With Sinopharm, Sinovac
The WHO's vaccine advisors recommended Monday that people over 60 who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered a third Covid-19 vaccine dose.
-
Countries Relying On Chinese Vaccines Reporting Covid Surge: Report
Countries like Mongolia, Seychelles and Bahrain had relied on the easily accessible Chinese COVID-19 vaccines to combat the coronavirus pandemic and bring back normalcy. These countries are now battling a surge in infections.
-
South Asian Nations Turn To China, Russia For COVID-19 Vaccine Supplies
Sri Lanka began injecting pregnant women with a Chinese coronavirus vaccine on Wednesday and Nepal resumed inoculations with a China-made jab as India's neighbours turn to Beijing and Moscow for help with supplies.
-
2 Vaccines From China's Sinopharm Successfully Contained Covid: Study
Vaccines from China's Sinopharm successfully contained Covid-19, according to a study published in a prestigious U.S. medical journal, the first time detailed findings from a late-stage trial of a Chinese shot have appeared in the scientific literatu
-
Bangladesh Gets 5 Lakh Chinese COVID-19 Vaccine Doses As Gift
Bangladesh on Wednesday received 500,000 doses of China's Sinopharm COVID-19 vaccine as a gift to continue its vaccination drive, which was halted due to shortage of India-made Astrazeneca jabs.
-
WHO Approves China's Sinopharm Covid Vaccine For Emergency Use
The World Health Organization on Friday approved the Sinopharm Covid-19 vaccine for emergency use -- the first Chinese jab to receive the WHO's green light.
-
Sri Lanka Puts China Vaccine On Hold, Will Use India-Made Shot
Sri Lanka has put Chinese Sinopharm's COVID-19 vaccine on hold and will use India-manufactured Oxford AstraZeneca vaccine to inoculate 14 million people, a government spokesperson has said.
-
Pakistan Receives First Batch Of China's Sinopharm Covid Vaccines
A Pakistan military aircraft brought back the country's first consignment of COVID-19 vaccines from China on Monday, the country's health adviser, Faisal Sultan, said.
-
China To Gift Half Million Doses Of Sinopharm Vaccine To Pakistan
Pakistan's Foreign Minister Shah Mehmood Qureshi said on Thursday that China has agreed to provide half a million doses of the Chinese Sinopharm COVID-19 free of cost to Pakistan by January 31.
-
Egypt Approves Chinese Sinopharm COVID-19 Vaccine
Egypt has approved the use of a Covid-19 vaccine developed by Chinese pharma giant Sinopharm with its rollout to start later in January, the health minister said.
-
Pakistan To Purchase 1.2 Million Covid Vaccine Doses From China's Sinopharm
Pakistan will purchase 1.2 million COVID-19 vaccine doses from China's Sinopharm , a minister said on Thursday, the first official confirmation of a vaccine purchase by the South Asian country as it battles a second wave of infections.
-
China Gives Its First Coronavirus Vaccine Approval To Sinopharm
China approved its first COVID-19 vaccine for general public use on Thursday, a shot developed by an affiliate of state-backed pharmaceutical giant Sinopharm, as it braces for greater transmission risks over the winter.
-
UAE Says China-Developed Sinopharm Covid Vaccine Has 86% Efficacy
An experimental coronavirus vaccine developed by China's Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
-
Almost A Million People Inoculated With Chinese Sinopharm Covid Vaccine
Nearly a million people have taken an experimental coronavirus vaccine developed by Chinese company Sinopharm, the firm said, although it has not yet provided any clear clinical evidence of efficacy.
-
UK To Recognise Covaxin, No Quarantine For Fully Vaccinated Travellers
Britain said it would recognise COVID-19 vaccines on the World Health Organization's Emergency Use Listing later this month, adding China's Sinovac, Sinopharm and India's Covaxin to the country's approved list of vaccines for inbound travellers.
-
WHO Experts Recommend 3rd Dose For Over-60s Jabbed With Sinopharm, Sinovac
The WHO's vaccine advisors recommended Monday that people over 60 who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered a third Covid-19 vaccine dose.
-
Countries Relying On Chinese Vaccines Reporting Covid Surge: Report
Countries like Mongolia, Seychelles and Bahrain had relied on the easily accessible Chinese COVID-19 vaccines to combat the coronavirus pandemic and bring back normalcy. These countries are now battling a surge in infections.
-
South Asian Nations Turn To China, Russia For COVID-19 Vaccine Supplies
Sri Lanka began injecting pregnant women with a Chinese coronavirus vaccine on Wednesday and Nepal resumed inoculations with a China-made jab as India's neighbours turn to Beijing and Moscow for help with supplies.
-
2 Vaccines From China's Sinopharm Successfully Contained Covid: Study
Vaccines from China's Sinopharm successfully contained Covid-19, according to a study published in a prestigious U.S. medical journal, the first time detailed findings from a late-stage trial of a Chinese shot have appeared in the scientific literatu
-
Bangladesh Gets 5 Lakh Chinese COVID-19 Vaccine Doses As Gift
Bangladesh on Wednesday received 500,000 doses of China's Sinopharm COVID-19 vaccine as a gift to continue its vaccination drive, which was halted due to shortage of India-made Astrazeneca jabs.
-
WHO Approves China's Sinopharm Covid Vaccine For Emergency Use
The World Health Organization on Friday approved the Sinopharm Covid-19 vaccine for emergency use -- the first Chinese jab to receive the WHO's green light.
-
Sri Lanka Puts China Vaccine On Hold, Will Use India-Made Shot
Sri Lanka has put Chinese Sinopharm's COVID-19 vaccine on hold and will use India-manufactured Oxford AstraZeneca vaccine to inoculate 14 million people, a government spokesperson has said.
-
Pakistan Receives First Batch Of China's Sinopharm Covid Vaccines
A Pakistan military aircraft brought back the country's first consignment of COVID-19 vaccines from China on Monday, the country's health adviser, Faisal Sultan, said.
-
China To Gift Half Million Doses Of Sinopharm Vaccine To Pakistan
Pakistan's Foreign Minister Shah Mehmood Qureshi said on Thursday that China has agreed to provide half a million doses of the Chinese Sinopharm COVID-19 free of cost to Pakistan by January 31.
-
Egypt Approves Chinese Sinopharm COVID-19 Vaccine
Egypt has approved the use of a Covid-19 vaccine developed by Chinese pharma giant Sinopharm with its rollout to start later in January, the health minister said.
-
Pakistan To Purchase 1.2 Million Covid Vaccine Doses From China's Sinopharm
Pakistan will purchase 1.2 million COVID-19 vaccine doses from China's Sinopharm , a minister said on Thursday, the first official confirmation of a vaccine purchase by the South Asian country as it battles a second wave of infections.
-
China Gives Its First Coronavirus Vaccine Approval To Sinopharm
China approved its first COVID-19 vaccine for general public use on Thursday, a shot developed by an affiliate of state-backed pharmaceutical giant Sinopharm, as it braces for greater transmission risks over the winter.
-
UAE Says China-Developed Sinopharm Covid Vaccine Has 86% Efficacy
An experimental coronavirus vaccine developed by China's Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
-
Almost A Million People Inoculated With Chinese Sinopharm Covid Vaccine
Nearly a million people have taken an experimental coronavirus vaccine developed by Chinese company Sinopharm, the firm said, although it has not yet provided any clear clinical evidence of efficacy.
